COMP <GO>
UVV vs TMO // EV/EBITDA & P/E VALUATION
Universal Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: UVV 3
— TMO 8
▲ EV/EBITDA & P/E VALUATION LEADER: UVV
LAST: $41.01 (+3.69%) • MKT CAP: $1.02B
valuation
7.4x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UVV VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UVV | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 16.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.60% | 9.30% | -2.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 7.4x | 30.4x | -23.00 | UVV | /valuation <GO> |
| Free Cash Flow Yield | 7.86% | 2.40% | +5.46 | UVV | /fcf-yield <GO> |
| Operating Margin | 5.80% | 17.40% | -11.60 | TMO | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 15.10% | -15.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.30% | 3.90% | -5.20 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 7.96% | 0.24% | +7.72 | UVV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.68 | 4.50 | -1.82 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.4 | 62.9 | -11.54 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.02B | $262.22B | -$261.20B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UVV REV | TMO REV | UVV GROSS % | TMO GROSS % | UVV FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.89B | $44.56B | 16.4% | — | $80.3M | $6.29B |
| FY 2024 | $2.92B | $42.88B | 17.9% | — | $264.4M | $7.27B |
| FY 2023 | $2.72B | $42.86B | — | — | -$74.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UVV // BETA —
TMO // BETA 0.94